AmericasHamas Survives, Palestine Thrives: Israel Retreats in Stunning Defeat — Its Disastrous Two-Year Assault Reverses Balance of Power10 Oct 2025
Business“People Died” — The Horizon Post Office Scandal: Britain’s Greatest Miscarriage of Justice9 Oct 2025
BusinessBTC, ETH, and XRP Prices Are Soaring! WOAMining Passive Income System Helps You Turn Volatility into Profit9 Oct 2025
AmericasIvy Cyber Launches Course Taught by CIA Whistleblower John Kiriakou and Yale Cybersecurity Expert Sean O’Brien9 Oct 2025
AmericasNorthLight Celebrates Two Years of Gazelle: Real-Time AI Analytics Driving Revenue Growth for CPG and Retail9 Oct 2025
EuropeDaniel Morgan: How the Phone Hacking Scandal Destroyed Britain’s Most Corrupted Murder Case8 Oct 2025
AmericasNew Evidence Points to Chaos at Zikim Beach on Oct. 7 — And Raises Fresh Questions About Israel’s Rules of Engagement8 Oct 2025
BusinessNew Clinical Results Highlight the Skincare Potential of Baltic Bladderwrack in Finnish Innovation by Saaren Taika8 Oct 2025
BusinessGlobal Report: Video Games Transcend Entertainment and Affect Positive Change in Players’ Lives8 Oct 2025
AmericasIsrael’s “12 Tribes” Network: Leaked Files Expose Billionaire-Funded Digital Militias and the Global Information War7 Oct 2025
AmericasThe Criminalization of Compassion: British Journalist Arrested After Israel's Illegal Sumud Flotilla Raid7 Oct 2025
AmericasIsrael’s High Seas Hostage-Taking: How the Sumud Flotilla Raid Amounts to an Act of War Against Every Flag State6 Oct 2025
AmericasGreta Thunberg Beaten and Humiliated After Israeli Forces Seize Gaza Aid Flotilla in International Waters6 Oct 2025
AmericasNorth Atlantic Announces Acquisition of Mountain High Appliance, Continuing Legacy of Family Ownership3 Oct 2025
AmericasUS Taxpayer Backlash Grows: Why Washington’s Israel Policy—and AIPAC’s Clout—Are Suddenly on the Defensive3 Oct 2025
AmericasIsrael’s Illegal Naval Blockade of Gaza Broken: ‘The Bravest People on Earth’ and the Voyage of the Mikeno2 Oct 2025
BusinessSepul Bio, an Innovative Business Unit of Théa, Doses First Participant in Phase 3 HYPERION Clinical Trial of Sepofarsen for CEP290-Associated Leber Congenital Amaurosis Type 101 Oct 2025